-
1“... of the present study is to investigate the pharmacoeconomic performance of the treatment with solifenacin, when...”
Get full text
Article -
2“...Objective: to evaluate pharmacoeconomic implications of the use of valsartan, an angiotensin II...”
Get full text
Article -
3“... impact of CINV are reviewed, as well as national pharmacoeconomic evalutations conducted on palonosetron...”
Get full text
Article -
4
-
5by Diego Bagnasco, Massimiliano Povero, Lorenzo Pradelli, Luisa Brussino, Giovanni Rolla, Marco Caminati, Francesco Menzella, Enrico Heffler, Giorgio Walter Canonica, Pierluigi Paggiaro, Gianenrico Senna, Manlio Milanese, Carlo Lombardi, Caterina Bucca, Andrea Manfredi, Rikki Frank Canevari, Giovanni Passalacqua, Gabriella Guarnieri, Vincenzo Patella, Foschino Barbaro Maria Pia, Elisiana Carpagnano, Anna del Colle, Giulia Scioscia, Pelaia Gerolamo, Pierluigi Paggiaro, Manuela Latorre, Francesca Puggioni, Francesca Racca, Elisabetta Favero, Sandra Iannacone, Eleonora Savi, Marcello Montagni, Gianna Camiciottoli, Chiara Allegrini, Giuseppe Spadaro, Caterina Detoraki, Carla Galeone, Patrizia Ruggiero, Monna Rita Yacoub, Alvise Berti, Gisella Colombo, Nicola Scichilone, Carmen Durante, Maria Teresa Costantino, Chiara Roncallo, Mariachiara Braschi, Francesco Blasi, Alice D'Adda, Erminia Ridolo, Massimo Triggiani, Roberta Parente, D'Amato Maria, Maria Vittoria Verrillo, Zappa Maria Cristina, Marianna Lilli, Nunzio Crimi, Marco Bonavia, Angelo Guido Corsico, Amelia Grosso, Stefano Del Giacco, Margherita Deidda, Luisa Ricciardi, Stefania Isola, Francesca Cicero, Giuliana Amato, Federica Vita, Antonio Spanevello, Patrizia Pignatti, Francesca Cherubino, Dina Visca, Eleonora Aletti, Fabio Luigi Massimo Ricciardolo, Vitina Maria Anna Carriero, Francesca Bertolini, Pierachille Santus, Roberta Barlassina, Andrea Airoldi, Giuseppe Guida, Nucera Eleonora, Arianna Aruanno, Angela Rizzi, Cristiano Caruso, Stefania Colantuono, Alessandra Arcolaci, Andrea Vianello, Fulvia Chieco Bianchi, Maria Rita Marchi, Stefano Centanni, Simone Luraschi, Silvia Ruggeri, Rocco Rinaldo, Elena Parazzini, Cecilia Calabrese, Martina Flora, Lorenzo Cosmi, Linda Di Pietro, Enrico Maggi, Laura Pini, Luigi Macchia, Danilo Di Bona, Luca Richeldi, Carola Condoluci, Leonello Fuso, Matteo Bonini, Alessandro Farsi, Giulia Carli, Paolo Montuschi, Giuseppe Santini, Maria Elisabetta Conte, Elisa Turchet, Carlo Barbetta, Francesco Mazza, Simona D'Alo, Stefano Pucci, Maria Filomena Caiaffa, Elena Minenna, Luciana D'Elia, Carlo Pasculli, Vittorio Viviano, Paolo Tarsia, Joyce Rolo, Mariacarmela Di Proietto, Salvatore Lo Cicero, Mariacarmela Di ProiettoSubjects: “...Pharmacoeconomics...”
Published 2021-02-01
Get full text
Article -
6“... is to describe the pharmacoeconomical profile of the drug in the Italian setting, focusing on the comparison...”
Get full text
Article -
7“... pharmacoeconomic model based on clinical data from DAVID and national economic parameters and demographics...”
Get full text
Article -
8by Lorenzo Pradelli“... of the pharmacoeconomic evidence published in the international literature is reviewed and implications in the Italian...”
Published 2005-12-01
Get full text
Article -
9by Lorenzo Pradelli“... in pharmacoeconomic comparisons among drugs used in that setting. For the purpose of this estimation, information...”
Published 2008-01-01
Get full text
Article -
10“.... Evidence from randomized controlled trials, observational and pharmacoeconomic studies suggest that SGLT2...”
Get full text
Article -
11by Lorenzo Pradelli“... to the pharmacoeconomical criteria, this very desiderable clinical goal is associated to a little increase of the health...”
Published 2005-09-01
Get full text
Article -
12“... carbomers’ characteristics in respect to other lacrimal substitutes. Then, a pharmacoeconomical analysis has...”
Get full text
Article -
13by Lorenzo Pradelli“... frame for its pharmacoeconomical evaluation. Terlipressin is the only vasoactive drug that demonstrated...”
Published 2005-03-01
Get full text
Article -
14“.... Starting from these clinical data, the second part outlines the pharmacoeconomical profile of the drug...”
Get full text
Article -
15“... other morphine-like agents. From a pharmacoeconomical point of view, tramadol prescription appears...”
Get full text
Article -
16“... the adherence to these recommendations, the better the clinical and economic outcomes. Pharmacoeconomic studies...”
Get full text
Article -
17“... are analyzed with a “value matrix”, a pharmacoeconomical technique for preliminary evaluations. The last...”
Get full text
Article -
18“.... In this article we present a flexible pharmacoeconomic model that permits the calculation of the marginal...”
Get full text
Article -
19“...OBJECTIVES: To estimate the pharmacoeconomical impact of preventing recurrent upper respiratory...”
Get full text
Article -
20“... pharmacoeconomical evaluation, we employed the data of an international multi-centric study that compared...”
Get full text
Article